Cargando…
Study protocol, rationale and recruitment in a European multi-centre randomized controlled trial to determine the efficacy and safety of azithromycin maintenance therapy for 6 months in primary ciliary dyskinesia
BACKGROUND: Clinical management of primary ciliary dyskinesia (PCD) respiratory disease is currently based on improving mucociliary clearance and controlling respiratory infections, through the administration of antibiotics. Treatment practices in PCD are largely extrapolated from more common chroni...
Autores principales: | Kobbernagel, Helene E., Buchvald, Frederik F., Haarman, Eric G., Casaulta, Carmen, Collins, Samuel A., Hogg, Claire, Kuehni, Claudia E., Lucas, Jane S., Omran, Heymut, Quittner, Alexandra L., Werner, Claudius, Nielsen, Kim G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957315/ https://www.ncbi.nlm.nih.gov/pubmed/27450411 http://dx.doi.org/10.1186/s12890-016-0261-x |
Ejemplares similares
-
Current and Future Treatments in Primary Ciliary Dyskinesia
por: Paff, Tamara, et al.
Publicado: (2021) -
Diagnosis and management of primary ciliary dyskinesia
por: Werner, Claudius, et al.
Publicado: (2015) -
The international primary ciliary dyskinesia cohort (iPCD Cohort): methods and first results
por: Goutaki, Myrofora, et al.
Publicado: (2017) -
Registries and collaborative studies for primary ciliary dyskinesia in Europe
por: Ardura-Garcia, Cristina, et al.
Publicado: (2020) -
One-year evolution and variability in multiple-breath washout indices in children and young adults with primary ciliary dyskinesia
por: Kobbernagel, Helene Elgaard, et al.
Publicado: (2019)